Nazione: Sudafrica
Lingua: inglese
Fonte: South African Health Products Regulatory Authority (SAHPRA)
Lennon
BRONCHETTE® CAPSULES BRONCHETTE® SYRUP SCHEDULING STATUS: S2 PROPRIETARY NAME (and dosage form): BRONCHETTE ® CAPSULES BRONCHETTE ® SYRUP COMPOSITION: Capsules: Each capsule contains 375 mg Carbocysteine . Syrup: Each 5 mL medicine measure contains: Carbocysteine 250 mg Preservative: Methyl hydroxybenzoate 0,17% m/v in a pleasantly flavoured syrup base. PHARMACOLOGICAL CLASSIFICATION: A10.1 Antitussives and Expectorants. PHARMACOLOGICAL ACTION: Carbocysteine reduces the viscosity of non-infected secretions from mucous cells in the respiratory tract. INDICATIONS: Adjunctive therapy in respiratory tract disorders characterised by excessive viscous mucous in the absence of infection. CONTRA-INDICATIONS: Active peptic ulcer. DOSAGE AND DIRECTIONS FOR USE: Capsules: Adults: 2 Capsules three times daily, reducing to 1 capsule four times daily when a satisfactory response has been obtained. Syrup: Adults: 2 - 3 medicine measures (10 - 15 mL) three times daily. Children (5 - 12 years): 9 medicine measure (5 mL) three times daily. (2 - 5 years): ½ medicine measure (2,5 mL) two to four times daily. (according to age) SIDE-EFFECTS AND SPECIAL PRECAUTIONS: Nausea, diarrhoea, headache. Caution must be exercised in patients with a history of gastric or duodenal ulcer. Safe use in pregnancy has not been established. KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT: See "Side effects and special precautions". Treatment is supportive and symptomatic. IDENTIFICATION: Capsules: Red and yellow capsules. Syrup: A brown flavoured syrup. Syrup: A brown flavoured syrup. PRESENTATION: Capsules: Containers of 30 and 100 capsules. Syrup: Bottles of 200 mL and 2,5 litres. STORAGE INSTRUCTIONS: Store below 25° C KEEP OUT OF REACH OF CHILDREN. REGISTRATION NUMBERS: Capsules M/10.1/212. Syrup L/10.1/320. Leggi il documento completo